Brittni Rodriguez
Optometrist · New York, NYNPI 1861047649
Payments from drug & device makers
Across 169 payments — averaging $28.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Bausch & Lomb Americas Inc.$629
- Biotissue Holdings Inc.$400
- Coopervision Inc.$376
- AbbVie$354
- Sun Pharmaceutical Industries Inc.$343
- plus $1K from 10 others
What the payments were for
- Food & beverage$4,779100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 79 | $1,469 |
| Bausch & Lomb Americas Inc. | 17 | $629 |
| Biotissue Holdings Inc. | 6 | $400 |
| Coopervision Inc. | 6 | $376 |
| AbbVie(2 entities) | 13 | $354 |
| Sun Pharmaceutical Industries Inc. | 16 | $343 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $270 |
| Novartis | 8 | $258 |
| Johnson & Johnson Vision Care, Inc. | 7 | $221 |
| Eyevance Pharmaceuticals LLC | 2 | $150 |
| Oyster Point Pharma, Inc. | 4 | $100 |
| Tarsus Pharmaceuticals, Inc. | 3 | $88 |
| Kala Pharmaceuticals, Inc. | 3 | $61 |
| Dompe US, Inc. | 1 | $24 |
| Amgen | 1 | $20 |
| Harrow Eye, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prokera$356
- AmnioGraft$356
- BIOTRUE ONE DAY$270
- INFUSE$142
- Clareon$141
- Rocklatan$125
- SIMBRINZA$125
- Rhopressa$125
- RESTASIS$124
- MIEBO$121
- XIIDRA$115
- RESTASIS MULTIDOSE$104
How this compares
$4,779 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 461 | $405,259 |
| XiidraLifitegrast | 201 | $176,798 |
| MieboPerfluorohexyloctane/Pf | 138 | $113,416 |
| Restasis MultidoseCyclosporine | 93 | $73,704 |
| LumiganBimatoprost | 171 | $68,638 |
| EysuvisLoteprednol Etabonate | 69 | $35,714 |
| Cyclosporine | 62 | $26,730 |
| RocklatanNetarsudil Mesylat/Latanoprost | 28 | $12,722 |
| CombiganBrimonidine Tartrate/Timolol | 27 | $11,606 |
| CequaCyclosporine | 13 | $11,408 |
| Prednisolone Acetate | 23 | $811 |
| Latanoprost | 75 | $633 |
| Azelastine Hcl | 24 | $425 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $317 |
| Brimonidine Tartrate | 12 | $300 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Restasis Multidose, Lumigan, Combigan | $354 | $559,208752 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $629 | $290,213339 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $61 | $35,71469 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $343 | $11,40813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,743 optometrist providers in New York.
Other optometrist in New York
- George ZikosNew York$1M
- Irene FrantzisNew York$663K
- Daphne AmbroseNew York$509K
- Susan ResnickNew York$463K
- Denise WhittamNew York$343K
- Jennifer TsaiNew York$275K
- Sophia VisanjiNew York$233K
- Danielle IaconoNew York$206K
- Jason ComptonNew York$197K
- John RobilottoNew York$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.